National Change In Cash vs Other Non Cash Items Analysis
NRC Stock | USD 19.66 0.18 0.92% |
National Research financial indicator trend analysis is infinitely more than just investigating National Research Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether National Research Corp is a good investment. Please check the relationship between National Research Change In Cash and its Other Non Cash Items accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Change In Cash vs Other Non Cash Items
Change In Cash vs Other Non Cash Items Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of National Research Corp Change In Cash account and Other Non Cash Items. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between National Research's Change In Cash and Other Non Cash Items is -0.47. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of National Research Corp, assuming nothing else is changed. The correlation between historical values of National Research's Change In Cash and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of National Research Corp are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Change In Cash i.e., National Research's Change In Cash and Other Non Cash Items go up and down completely randomly.
Correlation Coefficient | -0.47 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Change In Cash
Other Non Cash Items
Most indicators from National Research's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into National Research Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, National Research's Enterprise Value Over EBITDA is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 36.71, whereas Tax Provision is forecasted to decline to about 7.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 95.6M | 94.5M | 86.7M | 91.0M | Total Revenue | 148.0M | 151.6M | 148.6M | 156.0M |
National Research fundamental ratios Correlations
Click cells to compare fundamentals
National Research Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National Research fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 110.7M | 133.4M | 157.5M | 130.5M | 122.4M | 80.7M | |
Total Stockholder Equity | 32.9M | 64.3M | 85.3M | 72.0M | 49.0M | 45.4M | |
Other Assets | 5.4M | 8.9M | 9.8M | 5.7M | 6.6M | 6.9M | |
Common Stock Shares Outstanding | 25.7M | 25.7M | 25.6M | 25.1M | 24.7M | 14.8M | |
Liabilities And Stockholders Equity | 110.7M | 133.4M | 157.5M | 130.5M | 122.4M | 80.7M | |
Other Stockholder Equity | 128.4M | 128.1M | 123.8M | 97.2M | 79.5M | 83.4M | |
Total Liab | 77.8M | 69.1M | 72.2M | 58.4M | 73.5M | 77.2M | |
Other Current Liab | 12.2M | 10.9M | 17.0M | 12.6M | 12.6M | 7.2M | |
Total Current Liabilities | 38.2M | 31.7M | 40.4M | 33.4M | 36.2M | 23.7M | |
Property Plant And Equipment Net | 13.5M | 11.7M | 12.4M | 17.2M | 30.3M | 31.8M | |
Net Debt | 20.7M | (4.1M) | (27.8M) | (2.8M) | 32.3M | 33.9M | |
Retained Earnings | (93.4M) | (61.4M) | (36.1M) | (25.2M) | (30.5M) | (29.0M) | |
Accounts Payable | 4.9M | 1.1M | 1.9M | 1.2M | 1.3M | 1.2M | |
Cash | 13.5M | 34.7M | 54.4M | 25.0M | 6.7M | 6.3M | |
Non Current Assets Total | 81.5M | 79.3M | 83.8M | 86.7M | 98.1M | 58.5M | |
Non Currrent Assets Other | 10.1M | 10.3M | 9.8M | 7.9M | 4.7M | 4.5M | |
Cash And Short Term Investments | 13.5M | 34.7M | 54.4M | 25.0M | 6.7M | 6.3M | |
Net Receivables | 11.7M | 14.2M | 13.8M | 14.6M | 12.5M | 9.1M | |
Non Current Liabilities Total | 39.6M | 37.4M | 31.8M | 25.0M | 37.3M | 39.1M | |
Other Current Assets | 3.9M | 5.2M | 5.5M | 4.1M | 5.2M | 3.8M | |
Property Plant And Equipment Gross | 15.2M | 13.0M | 46.6M | 17.2M | 65.9M | 69.2M | |
Total Current Assets | 29.2M | 54.1M | 73.7M | 43.7M | 24.4M | 30.4M | |
Accumulated Other Comprehensive Income | (1.6M) | (2.9M) | (2.2M) | (2.4M) | (2.4M) | 0.0 | |
Short Long Term Debt Total | 34.7M | 30.6M | 26.5M | 22.2M | 39.0M | 40.9M | |
Intangible Assets | 1.7M | 1.4M | 1.8M | 1.6M | 1.5M | 1.4M | |
Short Term Debt | 4.4M | 5.0M | 5.2M | 5.3M | 7.2M | 7.6M | |
Other Liab | 8.1M | 10.9M | 9.5M | 6.9M | 8.0M | 8.4M | |
Long Term Debt | 29.8M | 26.5M | 22.3M | 17.7M | 29.5M | 30.9M | |
Treasury Stock | (33.7M) | (43.7M) | (50.1M) | (78.3M) | (70.4M) | (66.9M) | |
Property Plant Equipment | 13.5M | 11.7M | 12.4M | 17.2M | 19.8M | 14.1M | |
Current Deferred Revenue | 16.6M | 15.6M | 17.2M | 15.2M | 14.8M | 14.4M | |
Good Will | 57.8M | 57.9M | 57.3M | 61.6M | 55.5M | 52.7M | |
Retained Earnings Total Equity | (93.4M) | (61.4M) | (36.1M) | (25.2M) | (22.7M) | (21.5M) | |
Deferred Long Term Liab | 4.2M | 4.6M | 3.8M | 5.3M | 4.7M | 3.4M | |
Net Tangible Assets | 32.9M | 64.3M | 23.7M | 8.8M | 10.1M | 9.6M | |
Capital Surpluse | 162.2M | 171.8M | 173.9M | 175.5M | 201.8M | 110.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share 6.013 | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.